-
Je něco špatně v tomto záznamu ?
The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
I. Markova, D. Miklankova, M. Hüttl, P. Kacer, J. Skibova, J. Kucera, R. Sedlacek, T. Kacerova, L. Kazdova, H. Malinska,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-02-25
Open Access Digital Library
od 2013-01-01
Medline Complete (EBSCOhost)
od 2013-01-01
Nursing & Allied Health Database (ProQuest)
od 2013-01-01
Health & Medicine (ProQuest)
od 2013-01-01
Health Management Database (ProQuest)
od 2013-01-01
Public Health Database (ProQuest)
od 2013-01-01
Wiley-Blackwell Open Access Titles
od 2000
PubMed
31886287
DOI
10.1155/2019/8712979
Knihovny.cz E-zdroje
- MeSH
- albuminurie etiologie moč MeSH
- analýza moči MeSH
- biologické markery krev moč MeSH
- časná diagnóza MeSH
- časové faktory MeSH
- cytokiny moč MeSH
- epidermální růstový faktor moč MeSH
- hypertriglyceridemie krev komplikace genetika moč MeSH
- lipidy krev MeSH
- mediátory zánětu moč MeSH
- metabolický syndrom krev komplikace genetika moč MeSH
- modely nemocí na zvířatech MeSH
- nemoci ledvin krev etiologie moč MeSH
- potkani transgenní MeSH
- potkani Wistar MeSH
- prediktivní hodnota testů MeSH
- proteomika * MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Introduction: The development of metabolic syndrome-associated renal dysfunction is exacerbated by a number of factors including dyslipidemia, ectopic deposition of lipids and their toxic metabolites, impairment of lipid metabolism, and insulin resistance. Renal dysfunction is also affected by the production of proinflammatory and profibrotic factors secreted from adipose tissue, which can in turn directly impair kidney cells and potentiate insulin resistance. In this study, we investigated the manifestation of renal lipid accumulation and its effect on renal dysfunction in a model of metabolic syndrome-the hereditary hypertriglyceridemic rat (HHTg)-by assessing microalbuminuria and targeted urinary proteomics. Male Wistar control rats and HHTg rats were fed a standard diet and observed over the course of ageing at 3, 12, and 20 months of age. Results: Chronically elevated levels of triglycerides in HHTg rats were associated with increased levels of NEFA during OGTT and over a period of 24 hours (+80%, P < 0.01). HHTg animals exhibited qualitative changes in NEFA fatty acid composition, represented by an increased proportion of saturated fatty acids (P < 0.05) and a decreased proportion of n-3 PUFA (P < 0.01). Ectopic lipid deposition in the kidneys of HHTg rats-triglycerides (+30%) and cholesterol (+10%)-was associated with markedly elevated microalbuminuria as ageing increased, despite the absence of microalbuminuria at the young age of 3 months in these animals. According to targeted proteomic analysis, 3-month-old HHTg rats (in comparison to age-matched controls) exhibited increased urinary secretion of proinflammatory parameters (MCP-1, IL-6, IL-8, P < 0.01) and decreased urinary secretion of epidermal growth factor (EGF, P < 0.01) before manifestation of microalbuminuria. Elevation in the urinary secretion of inflammatory cytokines can be affected by increased relative expression of MCP-1 in the renal cortex (P < 0.05). Conclusions: Our results confirm dyslipidemia and ectopic lipid accumulation to be key contributors in the development of metabolic syndrome-associated renal dysfunction. Assessing urinary secretion of proinflammatory cytokines and epidermal growth factor can help in detecting early development of metabolic syndrome-associated renal dysfunction.
Czech University of Life Sciences 16500 Prague Czech Republic
Department of Chemistry University College London London WC1H 0AJ UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023348
- 003
- CZ-PrNML
- 005
- 20250618142113.0
- 007
- ta
- 008
- 201125e20191206xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2019/8712979 $2 doi
- 035 __
- $a (PubMed)31886287
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Markova, Irena $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic.
- 245 14
- $a The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach / $c I. Markova, D. Miklankova, M. Hüttl, P. Kacer, J. Skibova, J. Kucera, R. Sedlacek, T. Kacerova, L. Kazdova, H. Malinska,
- 520 9_
- $a Introduction: The development of metabolic syndrome-associated renal dysfunction is exacerbated by a number of factors including dyslipidemia, ectopic deposition of lipids and their toxic metabolites, impairment of lipid metabolism, and insulin resistance. Renal dysfunction is also affected by the production of proinflammatory and profibrotic factors secreted from adipose tissue, which can in turn directly impair kidney cells and potentiate insulin resistance. In this study, we investigated the manifestation of renal lipid accumulation and its effect on renal dysfunction in a model of metabolic syndrome-the hereditary hypertriglyceridemic rat (HHTg)-by assessing microalbuminuria and targeted urinary proteomics. Male Wistar control rats and HHTg rats were fed a standard diet and observed over the course of ageing at 3, 12, and 20 months of age. Results: Chronically elevated levels of triglycerides in HHTg rats were associated with increased levels of NEFA during OGTT and over a period of 24 hours (+80%, P < 0.01). HHTg animals exhibited qualitative changes in NEFA fatty acid composition, represented by an increased proportion of saturated fatty acids (P < 0.05) and a decreased proportion of n-3 PUFA (P < 0.01). Ectopic lipid deposition in the kidneys of HHTg rats-triglycerides (+30%) and cholesterol (+10%)-was associated with markedly elevated microalbuminuria as ageing increased, despite the absence of microalbuminuria at the young age of 3 months in these animals. According to targeted proteomic analysis, 3-month-old HHTg rats (in comparison to age-matched controls) exhibited increased urinary secretion of proinflammatory parameters (MCP-1, IL-6, IL-8, P < 0.01) and decreased urinary secretion of epidermal growth factor (EGF, P < 0.01) before manifestation of microalbuminuria. Elevation in the urinary secretion of inflammatory cytokines can be affected by increased relative expression of MCP-1 in the renal cortex (P < 0.05). Conclusions: Our results confirm dyslipidemia and ectopic lipid accumulation to be key contributors in the development of metabolic syndrome-associated renal dysfunction. Assessing urinary secretion of proinflammatory cytokines and epidermal growth factor can help in detecting early development of metabolic syndrome-associated renal dysfunction.
- 650 _2
- $a albuminurie $x etiologie $x moč $7 D000419
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $x krev $x moč $7 D015415
- 650 _2
- $a cytokiny $x moč $7 D016207
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a časná diagnóza $7 D042241
- 650 _2
- $a epidermální růstový faktor $x moč $7 D004815
- 650 _2
- $a hypertriglyceridemie $x krev $x komplikace $x genetika $x moč $7 D015228
- 650 _2
- $a mediátory zánětu $x moč $7 D018836
- 650 _2
- $a nemoci ledvin $x krev $x etiologie $x moč $7 D007674
- 650 _2
- $a lipidy $x krev $7 D008055
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolický syndrom $x krev $x komplikace $x genetika $x moč $7 D024821
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 12
- $a proteomika $7 D040901
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a analýza moči $7 D016482
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Miklankova, Denisa $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic.
- 700 1_
- $a Hüttl, Martina $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic.
- 700 1_
- $a Kacer, Petr $u Czech University of Life Sciences, 16500 Prague, Czech Republic.
- 700 1_
- $a Skibova, Jelena $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic.
- 700 1_
- $a Kucera, Jan $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech Republic.
- 700 1_
- $a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech Republic.
- 700 1_
- $a Kacerova, Tereza $u Department of Chemistry, University College London, London WC1H 0AJ, UK.
- 700 1_
- $a Kazdová, Ludmila, $d 1938-2025 $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic. $7 xx0053119
- 700 1_
- $a Malinska, Hana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic.
- 773 0_
- $w MED00181720 $t Journal of diabetes research $x 2314-6753 $g Roč. 2019 (20191206), s. 8712979
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31886287 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20250618142104 $b ABA008
- 999 __
- $a ok $b bmc $g 1595667 $s 1114024
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 2019 $c - $d 8712979 $e 20191206 $i 2314-6753 $m Journal of diabetes research $n J Diabetes Res $x MED00181720
- LZP __
- $a Pubmed-20201125